Cervical precancerous changes — Dr. Nishtha Tripathi Patel is an ESGO-certified gynaecological oncosurgeon offering specialist consultations and surgical care at Sterling Hospitals, KD Hospital and Welcare Speciality Hospital in Ahmedabad. This page covers cervical precancerous changes for patients, families and referring doctors looking for evidence-based, India-context information.
On this page
Cervical precancerous changes — What Does “Precancerous” Mean for the Cervix?
Cervical intraepithelial neoplasia (CIN) is the term used for abnormal cell changes in the surface layer of the cervix that have not yet invaded the underlying tissue. CIN is not cervical cancer — it is a pre-cancerous condition that, if left untreated, may or may not progress to cancer over several years. The majority of low-grade CIN regresses spontaneously, particularly in younger women whose immune systems clear the underlying HPV infection. High-grade CIN, however, carries a significant risk of progression and generally requires treatment.
The CIN Grading System
- CIN 1 (mild dyskaryosis) — affects the lower third of the cervical epithelium; 60–80% regress spontaneously; active surveillance rather than immediate treatment is usually appropriate
- CIN 2 (moderate dyskaryosis) — affects the lower two-thirds; intermediate risk; treatment is often recommended but surveillance may be appropriate in young women wishing to preserve fertility
- CIN 3 / HSIL (severe dyskaryosis) — affects full thickness; estimated 30–50% progression to invasive cancer over 10–20 years if untreated; treatment is uniformly recommended
How CIN Is Found
CIN produces no symptoms. It is found exclusively through cervical screening — either a Pap smear (identifying abnormal cells) or an HPV test (detecting the high-risk virus). Women with an abnormal smear or positive high-risk HPV test are referred for colposcopy — a clinical examination of the cervix under magnification with acetic acid and iodine to identify abnormal areas. A targeted biopsy is taken from any abnormal-appearing areas for histological confirmation.
Why CIN Matters
The entire rationale for cervical cancer screening rests on detecting and treating CIN before it becomes invasive cancer. A woman who receives and acts on her smear results and attends colposcopy when referred will, in almost all cases, never develop cervical cancer. The women I see with advanced cervical cancer have almost invariably either never been screened or had gaps in their screening history.
If you have been told your smear result is abnormal, do not panic — but do not delay. Attend your colposcopy appointment promptly.
Dr. Nishtha Tripathi Patel performs colposcopy and CIN treatment in Ahmedabad. Contact: +91 76988 00333.
Further Reading & Sources
Related Pages on This Site
Consultation and Next Steps
For an individualised consultation on cervical precancerous changes, share your reports on WhatsApp at +91 76988 00333. Dr. Nishtha Tripathi Patel provides a detailed assessment within 24-48 hours and arranges in-person consultation at Sterling Hospitals, KD Hospital, or Welcare Speciality Hospital in Ahmedabad based on your location and treatment requirements.
Bring the following to your first consultation: imaging studies (ultrasound, CT or MRI on CD), histopathology and biopsy reports, tumour marker results (CA-125, HE4, CEA where relevant), a list of current medications, and any prior treatment summaries. For patients travelling from outside Ahmedabad, scheduling can be arranged to complete consultation and any pre-op work-up in the fewest possible visits.
If you are exploring second-opinion options, see our second-opinion service page. Independent review of diagnosis, staging, and proposed treatment plans is provided at no cost via WhatsApp report review. You do not need to switch hospitals to obtain a second opinion.
For broader information about cervical precancerous changes and related conditions, also see our complete ovarian cancer guide, HIPEC India guide, cervical cancer guide and robotic surgery guide.